Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China

[1]  Wenbo Xu,et al.  Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018–2019 , 2021, Open forum infectious diseases.

[2]  J. Vertefeuille,et al.  Progress Toward Polio Eradication — Worldwide, January 2019–June 2021 , 2021, MMWR. Morbidity and mortality weekly report.

[3]  H. Shimizu,et al.  The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases , 2021, Viruses.

[4]  M. Pallansch,et al.  Progress Toward Poliovirus Containment Implementation — Worldwide, 2019–2020 , 2020, MMWR. Morbidity and mortality weekly report.

[5]  N. S. Morozova,et al.  Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage , 2020, Viruses.

[6]  Wenbo Xu,et al.  Molecular typing and characterization of a novel genotype of EV-B93 isolated from Tibet, China , 2020, PloS one.

[7]  O. Diop,et al.  Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[8]  Wenbo Xu,et al.  Implication of a High Risk of Type 2 Vaccine-Derived Poliovirus Emergence and Transmission after the Switch from tOPV to bOPV. , 2020, The Journal of infectious diseases.

[9]  Qi Chen,et al.  Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients. , 2020, Vaccine.

[10]  A. Aghamohammadi,et al.  Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran , 2019, Emerging infectious diseases.

[11]  Alice Mac Kain,et al.  Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process , 2019, Viruses.

[12]  R. Sutter,et al.  Progress Toward Poliovirus Containment Implementation — Worldwide, 2017–2018 , 2018, MMWR. Morbidity and mortality weekly report.

[13]  V. Agol,et al.  Pressure for Pattern-Specific Intertypic Recombination between Sabin Polioviruses: Evolutionary Implications , 2017, Viruses.

[14]  Wenbo Xu,et al.  Phylogenetic Characterizations of Highly Mutated EV-B106 Recombinants Showing Extensive Genetic Exchanges with Other EV-B in Xinjiang, China , 2017, Scientific Reports.

[15]  N. Rezaei,et al.  Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014 , 2016, Emerging infectious diseases.

[16]  R. Sutter,et al.  Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018 , 2016, MMWR. Morbidity and mortality weekly report.

[17]  Steven G F Wassilak,et al.  Progress Toward Polio Eradication - Worldwide, 2015-2016. , 2016 .

[18]  M. L. Yakovenko,et al.  A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus , 2016, Journal of Virology.

[19]  Wenbo Xu,et al.  An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses , 2015, Scientific Reports.

[20]  Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine — Worldwide, 2013–2016 , 2015, MMWR. Morbidity and mortality weekly report.

[21]  S. Plotkin,et al.  History of vaccination , 2014, Proceedings of the National Academy of Sciences.

[22]  Michael B. Schulte,et al.  Global RNA Structure Analysis of Poliovirus Identifies a Conserved RNA Structure Involved in Viral Replication and Infectivity , 2013, Journal of Virology.

[23]  Qi Chen,et al.  Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria , 2013, Journal of Virology.

[24]  Wenbo Xu,et al.  Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission. , 2010, The Journal of infectious diseases.

[25]  Wenbo Xu,et al.  Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis. , 2010, The Journal of general virology.

[26]  Qi Chen,et al.  Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. , 2008, Virus research.

[27]  Javier Martin,et al.  Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient , 2008, Journal of Virology.

[28]  O. Kew,et al.  Calibration of Multiple Poliovirus Molecular Clocks Covering an Extended Evolutionary Range , 2008, Journal of Virology.

[29]  R. Silverman,et al.  A Phylogenetically Conserved RNA Structure in the Poliovirus Open Reading Frame Inhibits the Antiviral Endoribonuclease RNase L , 2007, Journal of Virology.

[30]  Pei-Jer Chen,et al.  Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient , 2005, Journal of Virology.

[31]  M. Pallansch,et al.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication. , 2005, Annual review of microbiology.

[32]  W. Hall,et al.  Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child , 2004, Journal of Virology.

[33]  Lilly Yuen,et al.  Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001 , 2004, Journal of Virology.

[34]  A. Plebani,et al.  Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. , 2003, The Journal of general virology.

[35]  B L Trus,et al.  Three-dimensional structure of poliovirus receptor bound to poliovirus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Heim,et al.  Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. , 1999, Virology.

[37]  M. Pallansch,et al.  Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. , 1997, The Journal of infectious diseases.

[38]  P. Minor.  The molecular biology of poliovaccines. , 1992, The Journal of general virology.

[39]  J. Almond,et al.  Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. , 1989, Virology.

[40]  D. Evans,et al.  The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. , 1989, The Journal of general virology.

[41]  G. Schild,et al.  Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine , 1989, Journal of virology.

[42]  V. Blinov,et al.  Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. , 1989, Virology.

[43]  G. Schild,et al.  Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. , 1985, The Journal of general virology.

[44]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[45]  Update on vaccine-derived polioviruses worldwide, January 2016–June 2017. , 2017, Releve epidemiologique hebdomadaire.

[46]  G. Vernet,et al.  Circulating vaccine-derived polioviruses in the Extreme North region of Cameroon. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[47]  O. Kew,et al.  Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013. , 2014, MMWR. Morbidity and mortality weekly report.

[48]  Update on vaccine-derived polioviruses. , 2006, MMWR. Morbidity and mortality weekly report.

[49]  V. Agol,et al.  Circulating vaccine-derived polioviruses: current state of knowledge. , 2004, Bulletin of the World Health Organization.